文献速递精神分裂症与精神病性障碍物质与行为成瘾

伏隔核D2-MSN过度活跃驱动抗精神病药诱导的行为超敏

Accumbens D2-MSN hyperactivity drives antipsychotic-induced behavioral supersensitivity.
PubMed 文献 · Mol Psychiatry · 2021-08-04

长期抗精神病药治疗可导致行为超敏,表现为运动异常、症状难治和反跳性精神病,机制不明且无预防或逆转手段。研究发现行为超敏源于伏隔核核心D2-MSN的突触前后及突触周围可塑性改变,包括Ca2+通透性AMPA受体插入和D2受体依赖性IPSCs丢失。化学遗传学恢复D2-MSN的IPSCs可预防抗精神病药诱导的超敏,提示新治疗方向。

要点

  • 行为超敏与NAcore的D2-MSN突触可塑性改变相关。
  • D2-MSN过度活跃驱动可卡因运动敏化及成瘾相关表型。
  • 恢复D2-MSN的IPSCs可预防抗精神病药诱导的超敏。

核心结论

  • 行为超敏源于伏隔核核心D2-MSN持久的突触前后及突触周围可塑性,导致D2-MSN过度活跃。
  • 化学遗传学恢复D2-MSN的IPSCs足以预防抗精神病药诱导的超敏。

研究设计与样本

  • 动物实验研究,观察长期抗精神病药治疗后的行为超敏及伏隔核核心D2-MSN的可塑性变化。
  • 采用化学遗传学方法恢复D2-MSN的IPSCs以测试预防效果。

主要发现

  • 行为超敏伴随Ca2+通透性AMPA受体插入和D2受体依赖性IPSCs丢失。
  • D2-MSN过度活跃见于21%的D2-MSN亚群,并导致可卡因运动敏化。
  • 超敏与抗精神病药治疗抵抗和物质使用障碍的内表型相关,包括消退学习受损和线索诱导的可卡因寻求行为增强。

临床怎么用

  • 靶向恢复NAcore的D2-MSN抑制性突触传递可能成为预防或逆转抗精神病药诱导超敏的新策略。

局限性

  • 原文未报告研究样本量、物种、药物剂量及统计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antipsychotic-induced dopamine supersensitivity, or behavioral supersensitivity, is a problematic consequence of long-term antipsychotic treatment characterized by the emergence of motor abnormalities, refractory symptoms, and rebound psychosis. The underlying mechanisms are unclear and no approaches exist to prevent or reverse these unwanted effects of antipsychotic treatment. Here we demonstrate that behavioral supersensitivity stems from long-lasting pre, post and perisynaptic plasticity, including insertion of Ca2+-permeable AMPA receptors and loss of D2 receptor-dependent inhibitory postsynaptic currents (IPSCs) in D2 receptor-expressing medium spiny neurons (D2-MSNs) in the nucleus accumbens core (NAcore). The resulting hyperexcitability, prominent in a subpopulation of D2-MSNs (21%), caused locomotor sensitization to cocaine and was associated with behavioral endophenotypes of antipsychotic treatment resistance and substance use disorder, including disrupted extinction learning and augmented cue-induced cocaine-seeking behavior. Chemogenetic restoration of IPSCs in D2-MSNs in the NAcore was sufficient to prevent antipsychotic-induced supersensitivity, pointing to an entirely novel therapeutic direction for overcoming this condition.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kruyer A, Parrilla-Carrero J, Powell C, et al. Accumbens D2-MSN hyperactivity drives antipsychotic-induced behavioral supersensitivity. Mol Psychiatry. 2021. PMID: 34349226. doi:10.1038/s41380-021-01235-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。